JDD Webinars

Differentiating Approach to Acne Therapy: Women Vs. Men

By October 14, 2020April 22nd, 2021No Comments

Featured Article

Differentiating Approach to Acne Therapy: Women vs. Men

Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.

Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.

FACULTY


Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama

Watch Now

You May Also Like

Dermatology Roundup: Misinformation Fuels Sun Safety Decisions, According to AAD Survey

| Dermatology Roundup, Featured Articles, Latest News | No Comments
A survey of American adults finds online misinformation is a key factor in sun safety decision- making, including reducing or stopping sunscreen use. Results from the Practice Safe Sun Survey…
Journal of Drugs in Dermatology JDD featuring our current Author Spotlight features Brooke Bartley MD, one of the co-authors of Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel

Author Spotlight: Brooke Bartley MD

| Author Spotlight, Featured Articles, Latest News, Skin Cancer | No Comments
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Brooke Bartley MD, one of the co-authors of Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell…

The Emerging Role of Metformin in Skin Cancer: Mechanistic and Clinical Insights

| Featured Articles, Latest News, Oncodermatology, Skin of Color | No Comments
Metformin and Skin Cancer: Emerging Evidence for Dermatologic Oncology If you are curious about metabolic agents in dermatologic oncology this JDD article is a must read. A new review synthesizes…

Leave a Reply